Two distinct dysfunctions in diabetic mouse mesenteric artery contraction are caused by changes in the Rho A-Rho kinase signaling pathway

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 217-225

  Nobe, Koji ^a   Hashimoto, Terumasa ^a   Honda, Kazuo ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM ION; CHOLESTEROL; FATTY ACID; PHOSPHOLIPID; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; ENZYME ACTIVITY; ENZYME INACTIVATION; FATTY ACID BLOOD LEVEL; HYPERGLYCEMIA; LEAN BODY WEIGHT; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR TISSUE; WESTERN BLOTTING;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ANIMALS; ARTERIOLES; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HYPERGLYCEMIA; MALE; MESENTERIC ARTERY, INFERIOR; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PROTEIN KINASE INHIBITORS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84860452169     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.03.022     Document Type: Article

References (25)

1. Akiyoshi, J., Ieiri, S., Nakatsuji, T., Taguchi, T., 2009. Direct vasodilative effect of FK506 on porcine mesenteric artery in small bowel transplantation. J. Pediatr. Surg. 44, 2322-2326.
2. Arun, K.H., Kaul, C.L., Ramarao, P., 2004. High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta. Pharmacol. Res. 50, 561-568.
3. Beer, S., Feihl, F., Ruiz, J., Juhan-Vague, I., Aillaud, M.F., Wetzel, S.G., Liaudet, L., Gaillard, R.C., Waeber, B., 2008. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc. Health Risk Manag. 4, 1449-1458.
4. Belmadani, S., Palen, D.I., Gonzalez-Villalobos, R.A., Boulares, H.A., Matrougui, K., 2008. Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice. Diabetes 57, 1629-1637.
5. Bogdanov, V.Y., Osterud, B., 2010. Cardiovascular complications of diabetes mellitus: the tissue factor perspective. Thromb. Res. 125, 112-118.
6. Ding, Y.A., Cheng, H.C., Law, H.W., Yen, M.H., 1991. The role of endothelium in vascular response of diabetic rats. Zhonghua Yi Xue Za Zhi (Taipei) 47, 325-330.
7. Fischer, B., Boyer, J.L., Hoyle, C.H., Ziganshin, A.U., Brizzolara, A.L., Knight, G.E., Zimmet, J., Burnstock, G., Harden, T.K., Jacobson, K.A., 1993. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5?-triphosphate. J. Med. Chem. 36, 3937-3946.
8. Fitzgerald, S.M., Kemp-Harper, B.K., Parkington, H.C., Head, G.A., Evans, R.G., 2007. Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R707-R713.
9. Fulton, D.J., Hodgson, W.C., Sikorski, B.W., King, R.G., 1991. Attenuated responses to endothelin-1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 104, 928-932.
10. Grynkiewicz, G., Poenie, M., Tsien, R.Y., 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
11. Head, R.J., Longhurst, P.A., Panek, R.L., Stitzel, R.E., 1987. A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br. J. Pharmacol. 91, 275-286.
12. Kobayashi, T., Taguchi, K., Nemoto, S., Nogami, T., Matsumoto, T., Kamata, K., 2009. Activation of the PDK-1/Akt/eNOS pathway involved in aortic endothelial function differs between hyperinsulinemic and insulin-deficient diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 297, H1767-H1775.
13. Loirand, G., Guerin, P., Pacaud, P., 2006. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98, 322-334.
14. Martinez-Salas, S.G., Campos-Peralta, J.M., Pares-Hipolito, J., Gallardo-Ortiz, I.A., Ibarra, M., Villalobos-Molina, R., 2007. Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed. Auton. Autacoid Pharmacol. 27, 137-142.
15. Matsumoto, T., Miyamori, K., Kobayashi, T., Kamata, K., 2006. Specific impairment of endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from streptozotocin-induced diabetic mice. Vascul. Pharmacol. 44, 450-460.
16. Matsumoto, T., Nakayama, N., Ishida, K., Kobayashi, T., Kamata, K., 2009. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J. Pharmacol. Exp. Ther. 329, 324-334.
17. Matsumoto, T., Kobayashi, T., Ishida, K., Taguchi, K., Kamata, K., 2010. Enhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes. Br. J. Pharmacol. 160, 1092-1104.
18. Nobe, K., Paul, R.J., 2001. Distinct pathways of Ca(2+) sensitization in porcine coronary artery: effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca(2+). Circ. Res. 88, 1283-1290.
19. Nobe, K., Suzuki, H., Sakai, Y., Nobe, H., Paul, R.J., Momose, K., 2004. Glucose-dependent enhancement of spontaneous phasic contraction is suppressed in diabetic mouse portal vein: association with diacylglycerol-protein kinase C pathway. J. Pharmacol. Exp. Ther. 309, 1263-1272.
20. Nobe, K., Hagiwara, C., Nezu, Y., Honda, K., 2006. Distinct agonist responsibilities of the first and second branches of mouse mesenteric artery. J. Cardiovasc. Pharmacol. 47, 422-427.
21. Pang, H., Guo, Z., Su, W., Xie, Z., Eto, M., Gong, M.C., 2005. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 289, C352-C360.
22. Pannirselvam, M., Ding, H., Anderson, T.J., Triggle, C.R., 2006. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur. J. Pharmacol. 551, 98-107.
23. Porszasz, R., Porkolab, A., Ferencz, A., Pataki, T., Szilvassy, Z., Szolcsanyi, J., 2002. Capsaicininduced nonneural vasoconstriction in canine mesenteric arteries. Eur. J. Pharmacol. 441, 173-175.
24. Silan, C., 2008. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 31, 897-902.
25. Xie, Z., Su, W., Guo, Z., Pang, H., Post, S.R., Gong, M.C., 2006. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc. Res. 69, 491-501.